stockrowMediciNova, Inc. (MNOV) vs Rani Therapeutics Holdings, Inc. (RANI)
- MediciNova, Inc. MNOV 1.46 +0.69%
- Rani Therapeutics Holdings, Inc. RANI 0.54 +3.85%
MediciNova, Inc. and Rani Therapeutics Holdings, Inc. are both Biotechnology companies. MediciNova, Inc. and Rani Therapeutics Holdings, Inc. are of similar size ($72.0M and $71.4M). Rani Therapeutics Holdings, Inc. grew revenue faster over the last twelve months: 78.7% against −82.2%. Rani Therapeutics Holdings, Inc. has the higher net margin (−597.0% vs −1,168.3%) and the higher return on invested capital (0.00% vs −62.5%). Across the 16 metrics below, Rani Therapeutics Holdings, Inc. leads on 10 and MediciNova, Inc. on 6.
Valuation
Profitability
| Metric | MNOV | RANI | Biotechnology median |
|---|---|---|---|
| Gross margin | 37.76% | 100.00% | 68.51% |
| Operating margin | (1,287.53%) | (652.78%) | 0.00% |
| Net margin | (1,168.31%) | (596.97%) | 0.00% |
| Free cash flow margin | (991.31%) | (402.83%) | 0.00% |
| Return on equity | (25.56%) | (155.24%) | (51.96%) |
| Return on assets | (23.83%) | (77.54%) | (46.06%) |
| Return on invested capital | (62.48%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack